Patents for A61P 23 - Anaesthetics (4,141)
04/2008
04/09/2008EP1908458A1 Volatile anaesthetic with xenon
04/09/2008CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives
04/02/2008EP1905757A1 Derivatives of Venlafaxine and methods of preparing and using the same
04/02/2008EP1905436A1 Synergistic time-delaying agent for local anestheic
04/02/2008CN101155580A Propofol-containing fat emulsion
04/01/2008US7350331 Method for producing metabolites from plants cultivated in soil-less medium
03/2008
03/27/2008WO2008036980A1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
03/27/2008WO2008036858A2 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
03/27/2008CA2663857A1 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
03/27/2008CA2663515A1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
03/26/2008CN100376232C Anaesthetic formulations
03/20/2008US20080070939 Use of dextromethorphan hydrobromide monohydrate, dextrorphan tartrate, or 3-methoxymorphinan hydrochloride
03/20/2008US20080070911 Ion channel modulating compounds and uses thereof
03/19/2008EP1300141B1 Medical composition kit for treating lesioned abnormal tissue
03/18/2008CA2454328C Pharmaceutical combinations of oxycodone and naloxone
03/18/2008CA2329128C Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
03/12/2008CN101139341A Indazolamides with analgesic activity
03/12/2008CN100374161C Triacetin as a transdermal penetration enhancer
03/11/2008CA2310664C Substituted 2-aminoacetamides and the use thereof
02/2008
02/28/2008WO2008024006A2 Pharmaceutical preparation in a gel form
02/28/2008WO2008022541A1 Water-soluble derivatives of anesthetic 2,6-diisopropylphenol and preparation method thereof
02/28/2008CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives
02/27/2008EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
02/27/2008EP1891063A2 Bicyclic derivatives as modulators of ion channels
02/27/2008EP1891010A2 A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide
02/21/2008US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
02/20/2008EP1888558A1 Bicyclic derivatives as modulators of ion channels
02/14/2008DE102006037495A1 Use of substances with pharmacological action e.g. xenon for producing a preparation, in which components of the preparation are a gas or a lightly volatile fluid, for administration of the substances to humans or animals over the eyes
02/13/2008CN100367943C Propofol-containing fat emulsions
02/13/2008CN100367927C Drug delivery of phase changing formulation
02/12/2008CA2303432C Modulation of drug loading in multivesicular liposomes
02/06/2008EP1884241A1 A oral preparation comprising dyclonine hydrochloride
02/06/2008EP1883392A2 Process for preparation of isotonic aqueous injection of ropivacaine
01/2008
01/31/2008WO2008011670A1 Trauma therapy
01/31/2008US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic
01/31/2008CA2692256A1 Trauma therapy
01/29/2008CA2505487C Levobupivacaine and its use as an anaesthetic in obstetrics
01/24/2008WO2008011539A2 Anesthetic compounds
01/24/2008CA2656510A1 Anesthetic compounds
01/22/2008CA2347976C Plastics container containing stabilised drug formulations
01/22/2008CA2222676C New pharmaceutical composition with anaesthetic effect
01/17/2008WO2008007554A1 Adhesive preparation
01/17/2008CA2657592A1 Adhesive patch containing fentanyl or a pharmaceutically acceptable salt thereof
01/16/2008EP1877556A2 USE OF ANTI-TNF OR ANTI-ILl RNAI TO SUPPRESS PRO- INFLAMMATORY CYTOKINE ACTIONS LOCALLY TO TREAT PAIN
01/16/2008CN101104591A Polymorph of proparacaine hydrochloride and preparation method thereof
01/15/2008US7319092 Methods of suppressing microglial activation
01/09/2008EP1875901A1 Propofol-containing fat emulsion
01/09/2008EP1318797B1 Volatile anaesthetic with xenon
01/08/2008US7317034 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds
01/03/2008DE10245212B4 Verwendung säurehaltiger Mittel zur Desensibilisierung von Zähnen Using acidic agent for desensitization of teeth
01/02/2008CN100358513C Disoprofol injection preparation process
12/2007
12/21/2007WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/20/2007US20070292461 Oleaginous pharmaceutical and cosmetic foam
12/13/2007US20070287970 Method for systemic drug delivery through the nail
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/11/2007CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification
12/05/2007CN100352816C Nociceptin analogs
11/2007
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/22/2007US20070269465 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
11/22/2007US20070269393 Topical anesthetic formulation
11/21/2007EP1608381B1 Therapeutic and consmetic application for a composition containing lycopene
11/15/2007WO2007093617A3 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
11/15/2007US20070264373 Toxin Induced Sympathectomy
11/14/2007EP1853240A2 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
11/14/2007EP1294659B1 Process for isolating enantiomers of cetamine
11/13/2007US7294345 Otorhinological delivery device
11/07/2007EP1850863A1 Use of botulinum toxin for prolonged local desensitization
11/07/2007EP1401408A4 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/07/2007CN100347168C Indazolamides with analgesic activity
11/01/2007WO2007121976A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
11/01/2007CA2641139A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/2007
10/31/2007CN101062019A Lappaconitine hydrobromide transparent patch and the preparing method thereof
10/31/2007CN101062012A Narcotic analgesics injection liquid
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007CA2216583C Levobupivacaine and its use as an anaesthetic in pregnant women
10/25/2007US20070249730 Intravenous Propofol emulsion compositions having preservative efficacy
10/25/2007US20070249681 Blocking both sensory and motor nerves by using an anesthetic comprising a mixture of levobupivacaine and dextrobupivacaine or salts in the ratio of 75:2; cardiotoxic profile similar to that of enantiomeric pure levobupivacaine; optics; efficiency
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/24/2007EP1847542A1 Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
10/24/2007CN101057845A Bulleyaconitin A dry emulsion and its preparation method and application
10/23/2007US7285517 Warming and nonirritating lubricant compositions and method of comparing irritation
10/17/2007EP1844000A1 Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
10/10/2007CN101050200A 1 ¿C olefin substitutional N (2,6 dimethyl phenyl) - 2 ¿C piperidine formamide derivative
10/04/2007WO2007111371A1 Agent for amelioration of hyperesthetic skin itching
10/04/2007WO2007111370A1 Agent for external application to the skin
10/04/2007US20070232641 exo-3-(3,4-Dichloro-phenoxy)-9-methyl-9-aza-bicyclo[3.3.1]nonane; central nervous system disorders
10/03/2007EP1838301A1 Use of resiniferatoxin (rtx) for producing an agent for treating joint pains and method for applying said agent
10/03/2007EP1187916B1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
10/03/2007CN101045042A Propofol injection and its preparing method
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276504 Nasally administering an imidazotriazinone substituted with an (alkoxy)(aminosulfonyl)phenyl group for treating diseases including psoriasis, female infertility, diabetes, glaucoma, cystic fibrosis, pre-eclampsia, Parkinsonism, tinnitus, pain, gastric motility disorders, and pulmonary hypertension
09/2007
09/26/2007EP1265596B1 Medical emulsion for lubrication and delivery of drugs
09/26/2007CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives
09/25/2007US7273952 Substituted C-cyclohexylmethylamine derivatives
09/12/2007EP1830856A2 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
09/12/2007EP1830836A1 Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller
09/12/2007EP1830835A1 Use of a vanilloid receptor agonist together with a glycosaminoglycan or proteoglycan for producing an agent for treating articular pains and method for applying said agent
09/12/2007CN101032468A Long-cycled lipid emulsion profofol preparation
09/11/2007CA2447210C Delivery of aerosols containing small particles through an inhalation route
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 42